Celadon Pharma. Regulatory News (CEL)

For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Celsis International Plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

North Atlantic Value LLP (as investment manager/advisor)

4. Full name of shareholder(s) (if different from 3):

1. Oryx International Growth Fund Limited

2. North Atlantic Smaller Companies Investment Trust Plc

5. Date of transaction (and date on which the threshold is crossed or reached if different):

17 Marh 2009

6. Date on which issuer notified:

18 March 2009

7. Threshold(s) that is/are crossed or reached:

Total holding increased through 19%

Individual holding through 12%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

Ordinary shares

Sedol: BOCD5F6

Holder 1

Holder 2

1,500,000

2,546,440

1,500,000

2,546,440

1,500,000

2,710,673

1,500,000

2,710,673

TOTAL:

6.85%

12.38%

19.23%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

4,210,673

19.23%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Not applicable

Proxy Voting:

10. Name of proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

North Atlantic Value LLP is the investment manager/advisor in respect of the full 19.23% holding as it is investment manager to Holder 1 as well as Holder 2.

14 Contact name:

Bonita Guntrip

15. Contact telephone number:

020 7747 5681